Navire
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1800 Owens St Fl 12, San Francisco, Cali...Website
www.navirepharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Navire
Navire Pharma is focused on developing SHP2 inhibitors as innovative treatments for challenging cancers. Their lead compound, BBP-398, targets tumors driven by mutations in the MAPK signaling pathway and is currently undergoing multiple clinical studies. The company collaborates with leading cancer research institutions, including the University of Texas MD Anderson Cancer Center, to advance their therapeutic offerings. Navire Pharma is a subsidiary of BridgeBio, which aims to create transformative medicines for genetic diseases and cancers with clear genetic drivers.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Navire your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Navire, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Navire had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Navire has new funding data
Product Launch: Get notified when Navire launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Navire has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Navire recently announced quarterly report
Check out if Navire is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Navire
Recommended Actions
Reach out to Masked Content who joined Navire as Masked Content
Find more new buyers
Compare Similar Companies to Navire
Compare insights from companies similar to Navire, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Navire
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Navire is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Navire is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Navire.
Navire Tech Stack
A closer look at the technologies used by Navire
See more technologies
Navire News & Media
BridgeBio Pharma Expands Reach Into China and Other Major Asian Markets Through Strategic Collaboration With Perceptive Advisors-Founded Company, LianBio
$26.5 million total near-term payments to BridgeBio, plus participation in long-term value creation of up to $505 million in milestone payments, tiered double-digit royalty payments and an equity interest in LianBio.Perceptive Advisors Launches LianBio with Multiple Strategic Alliances and Establishes Operating Platform
SHANGHAI & PRINCETON, N.J.--(BUSINESS WIRE)---- $BBIO #BridgeBio--Perceptive Advisors launches LianBio with multiple strategic alliances to develop and commercialize therapeutics in China and major Asian markets.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Navire
Sign Up For FreeTo access detailed company insights
Navire Pharma is focused on developing SHP2 inhibitors as innovative treatments for challenging cancers. Their lead compound, BBP-398, targets tumors driven by mutations in the MAPK signaling pathway and is currently undergoing multiple clinical studies. The company collaborates with leading cancer research institutions, including the University of... Read More
